Global healthcare technology and services group, Clanwilliam, has launched a brand-new ANZ division backed by an experienced leadership team.
The new division will bring together four leading technology products with a track record of delivering healthcare innovation across New Zealand and Australia.
The division, comprising of leading healthcare technology products: HealthLink (market leading secure messaging vendor), Konnect NET (medical information request platform for insurers), Toniq (pharmacy software), and MBS (anaesthetic private practice software), builds on the successful merger of HealthLink and Konnect NET operations in December 2020, bringing further structure to Clanwilliam’s expanding ANZ portfolio.
Commitment to driving digital innovation
Led by Mike Weiss, Managing Director (New Zealand), David Young, Managing Director (Australia) and Andrew Grant, Director of Technology, the creation of the ANZ division will encourage the exchange of ideas and technology between the experienced teams and create a focus for investment in solutions to support the national healthcare strategic agendas.
Clanwilliam Founder and Group Chief Executive Officer, Howard Beggs, said: “Our technology has been in use in multiple healthcare environments across ANZ for over two decades, from the delivery of national e-referral and SmartForm initiatives, to the management of pharmacies and private practices across the countries. This renewed focus and commitment to the region, leveraging our strengths, shared relationships, and shared knowledge will help us continue to support our strategic partners and wider healthcare stakeholders with their digital transformation plans.
“The creation of our ANZ division further reinforces our commitment to driving digital innovation in the region, and developing technology to help address current and future challenges in line with national health strategies.
“We are investing substantially in our technology platforms – particularly in API and FHIR based messaging solutions – to drive interoperability, better connected and more agile healthcare delivery, and the best possible patient outcomes across the region.”
Since 2017, Clanwilliam, headquartered in Ireland, has invested more than NZ$100 million in the Australasian healthcare technology market. Clanwilliam remains committed to delivering innovative healthcare technology that supports healthcare professionals in delivering great care to their patients, with the division being an anchor for Clanwilliam’s continued growth, innovation and investment in the Australasian market.
Connecting healthcare globally
Clanwilliam was founded in 1996 by Howard Beggs to help doctors utilise technology to deliver better care. Today, Clanwilliam is a global healthcare group of more than 25 technology products and services committed to improving healthcare across the world.
It has 16 offices and more than 1,050 staff in the UK, Ireland, New Zealand, Australia, and India, serving healthcare customers in over 20 countries.
In total, the Clanwilliam ANZ division has a presence in more than 50,000 practices, hospitals and health enterprises. Other global Clanwilliam products are used by hundreds of thousands of professionals in community pharmacies, private practices, GP Practices, hospitals and NHS Trusts across the world.
Photo features the Clanwilliam ANZ Leadership Team [L-R from back] Mike Weiss (Managing Director – New Zealand), Andrew Grant (Director of Technology), Dave Young (Managing Director – Australia), and Howard Beggs (Group Founder and CEO)